Drugs / Lang Qingata
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06193629 | Mar → Dec 2024 | metabolic dysfunction-associated steatohepatitis | Shupei Li | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lang Qingata | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06193629 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Tibetan Drug Langqing Atar” NCT06193629 ↗ |
| Route | Oral | “Decoction in water for oral use” NCT06193629 ↗ |